Your browser is no longer supported. Please, upgrade your browser.
IBB iShares Nasdaq Biotechnology ETF daily Stock Chart
iShares Nasdaq Biotechnology ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.65%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-2.02%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-13.45%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.82 Perf Half Y-8.39%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-4.49%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range100.22 - 122.97 Perf YTD-4.53%
Dividend0.30 P/FCF- EPS past 5Y- ROI- 52W High-17.11% Beta-
Dividend %0.29% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low1.71% ATR2.77
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)37.97 Volatility2.39% 2.62%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.78 Prev Close103.89
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.06M Price101.93
Recom- SMA20-2.96% SMA50-5.48% SMA200-8.23% Volume1,614,389 Change-1.89%
Dec-13-18 07:32AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Dec-12-18 03:17AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen Zacks
Dec-11-18 03:32PM  Trump Foreshadows a Bleak Outlook for Biotech (IBB, BIB) Investopedia
Dec-10-18 09:24AM  IBBs $100 Support Level Goes Back to 2017 InvestorPlace
Dec-07-18 11:48AM  Shares of Moderna open at $22, 4% lower than IPO price MarketWatch
Dec-04-18 02:08PM  Revance Therapeutics reaches licensing agreement with Fosun Pharmaceutical over botox formulation RT002 MarketWatch
Nov-26-18 07:07AM  Zafgen's IND for diabetes treatment placed on hold by FDA MarketWatch
Nov-21-18 02:17PM  Pfizer Stock Has Multiple Positive Catalysts InvestorPlace
09:47AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Nov-20-18 02:03PM  7 Biotech ETFs to Consider for 2019 InvestorPlace
Nov-14-18 03:09PM  Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels MarketWatch
Nov-11-18 09:10AM  The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs Benzinga
Nov-07-18 09:55AM  MiMedx stock plunges after receiving delisting notice from Nasdaq MarketWatch
Nov-02-18 05:18PM  Stocks finish lower after a volatile trading session Yahoo Finance Video
05:12PM  Newman: GOP still trying to kill the Affordable Care Act Yahoo Finance Video
08:52AM  Puma Biotechnology's stock plunges to pace premarket losers after key drug Nerlynx disappoints MarketWatch
Nov-01-18 04:09PM  Small Cap Stocks, Chips Lead Broad Gains, But This Group Surprisingly Lags Investor's Business Daily
Oct-25-18 05:41PM  Technician reacts to Gilead earnings and the biotech spac... CNBC Videos
08:00AM  Chip Stocks Plunge In Severe Market Rout, But These Sectors Rise Investor's Business Daily
Oct-19-18 12:15PM  Biotech Sector Could Enter Bear Market Investopedia
07:46AM  Merrimack Pharmaceuticals' stock plummets toward record low after cancer drug trial terminated MarketWatch
Oct-12-18 11:15AM  Equillium's stock opens 2.5% above IPO price MarketWatch
08:57AM  Immune Design's stock plummets toward record low after cancer vaccine program discontinued MarketWatch
08:16AM  Corium's stock rockets to pace premarket gainers after Gurnet buyout deal MarketWatch
Oct-10-18 12:56PM  Biotech ETF IBB is down 6% in one way, here's why CNBC Videos
Oct-04-18 11:35AM  Kodiak Sciences' stock trades little changed in its debut, after the IPO prices well below the expected range MarketWatch
10:55AM  Guardant Health's stock soars in public debut after IPO prices above expectations MarketWatch
08:47AM  Vaxart's stock soars after upbeat results from oral flu vaccine trial MarketWatch
Oct-03-18 05:30PM  Chartmaster says it's time to fade one of this year's bes... CNBC Videos
Sep-27-18 08:04AM  Geron's stock plunges to pace all premarket losers after Janssen terminates CLA MarketWatch
Sep-26-18 08:12AM  Alderya's stock rockets after positive trial results of mesothelioma treatment MarketWatch
06:51AM  Alexion Pharmaceuticals to buy Syntimmune for up to $1.2 billion, including potential milestone payments MarketWatch
Sep-24-18 09:20AM  Three options strategies for the week: Sept 24 CNBC
07:45AM  Epizyme's stock soars after FDA lifts hold on trial enrollments MarketWatch
Sep-21-18 02:30PM  Is iShares Nasdaq Biotechnology ETF a Buy? Motley Fool
09:09AM  Novavax's stock soars after J.P. Morgan swings to bullish from bearish ahead of trial results MarketWatch
Sep-19-18 09:41AM  G1 Therapeutics' stock drops on heavy volume after stock offering MarketWatch
08:15AM  Molecular Templates' stock soars after development deal with Takeda MarketWatch
Sep-17-18 07:56AM  Gritstone Oncology sets terms for IPO to raise up to $91.1 million MarketWatch
07:24AM  Realm Therapeutics launches review that may include a sale after disappointing trial results MarketWatch
Sep-12-18 06:00PM  Bluebird Bio Stock May Have Upside of at Least 60 Percent InvestorPlace
Sep-11-18 10:57AM  Vivus stock rallies above $5 mark in volatile trade after reverse stock split takes effect MarketWatch
Sep-10-18 01:23PM  Three options strategies for the week: Sept 10 CNBC
Sep-07-18 02:10PM  Arrowhead Stock Is Not Done Rallying After Its 38% Jump InvestorPlace
Aug-31-18 05:35PM  Biotech Fund Flows, Including ETF Activity, Remain a Driver to Watch ETF Trends
11:45AM  IBB at a two-year high, on pace for best week since first... CNBC Videos
Aug-29-18 02:00PM  3 Stocks That May Lead a Massive Biotech Breakout Investopedia
Aug-28-18 09:18AM  Strong Bullish Breakout for Biotech Sector ETF Investopedia
Aug-23-18 11:39AM  7 Cheap Biotech Stocks to Buy Now InvestorPlace
03:17AM  These 7 little-known health-care ETFs are up 20%-plus in 2018 MarketWatch
Aug-22-18 03:22PM  7 Healthcare ETFs Among Best Performing Defensive Picks This Year ETF Trends
Aug-10-18 07:04AM  Gemphire Therapeutics stock plunges after trial halted due to 'unanticipated problems' MarketWatch
Aug-08-18 09:34AM  Ampio's stock plunges below $1 threshold after FDA comments on clinical trial MarketWatch
07:59AM  Despite Recent Volatility, Biotech Stocks Look Poised to Pop Investopedia
Aug-02-18 12:55PM  Adding Biotech ETFs to Your Portfolio Investopedia
Jul-31-18 03:52PM  Biotech ETFs Rally as Illumina Tops Q2 Expectations ETF Trends
Jul-25-18 08:36AM  ResTORbio's stocks rockets on positive trial results, just as post-IPO lock up expires MarketWatch
Jul-24-18 10:25AM  Biotech ETFs surge, supported by strong results from Biogen and Eli Lilly MarketWatch
Jul-19-18 08:00AM  Trending: Disillusioned Investors Punish Netflix Stock Due to Subscriber Shortfall ETF Database
Jul-17-18 07:01PM  Cramer's charts suggest big-name biotech stocks Gilead an... CNBC Videos
10:16AM  EARNINGS: United Health slumps after guidance disappoints Wall Street Yahoo Finance Video
Jul-10-18 11:54AM  Trump Tweets Threat to Pfizer but Investors Shrug it Off InvestorPlace
Jul-06-18 05:29PM  Is health care the ultimate hideout trade? CNBC Videos
01:50PM  Biotech ETFs Climb on Biogens Promising Clinical Trial ETF Trends
11:54AM  Dont Buy Biogen Stock on the Promise of an Alzheimers Breakthrough InvestorPlace
10:44AM  Biotech ETFs surge, lifted as Biogen sees best session in more than a decade MarketWatch
09:06AM  Exposure to Feverish Biogen Should Give These 2 Biotech ETFs Booster Shots
Jul-05-18 02:40PM  Drug pricing debate could heat up in July CNBC Videos
11:46AM  Go Long Pfizer Stock Its an Easy Pill to Swallow InvestorPlace
10:21AM  It May Be Imperfect, but Celgenes Growth Is Worth Taking Note of InvestorPlace
Jun-01-18 04:40PM  Conquering cancer in the Windy City CNBC Videos
May-31-18 01:46PM  Analysis: White House Takes Bully Pulpit Approach On Drug Pricing Reform, Congress Unlikely To Act Benzinga
07:33AM  Trade of the Day: Amgen, Inc. Clears a Breakout Hurdle InvestorPlace
06:45AM  2 ETFs to Help You Build Retirement Wealth Motley Fool
May-30-18 11:43AM  Biotech ETFs Are the Best Way to Play the Recovering Sector InvestorPlace
May-25-18 10:22AM  Biotech Stocks Could Lead Summer Rally Investopedia
May-17-18 11:27AM  Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks InvestorPlace
May-16-18 02:37PM  MARKETS: Russell 2000 hits all-time high; Walmart earnings on deck; oil prices reverse; healthcare stocks in focus Yahoo Finance Video
12:08PM  Teva Pharmaceutical Industries Ltd, Once a Falling Machete, Is Spiking Chase It InvestorPlace
May-14-18 07:33AM  5 Top Stock Trades for Monday Morning InvestorPlace
May-11-18 05:02PM  Trump lets drug companies off the hook Yahoo Finance Video
01:50PM  Yahoo Finance Live: The Final Round - May 11th, 2018 Yahoo Finance Video
07:27AM  5 Top Stock Trades for Friday Morning InvestorPlace
May-04-18 11:44AM  Biotech Stocks Set to Breakout Investopedia
May-01-18 12:09PM  Pfizer falls to session low CNBC Videos
Apr-25-18 01:25PM  3 Charts That Suggest Biotech Stocks Are Headed Lower Investopedia
06:00AM  Why Biogen's Stock Rebound Is Good News for Biotechs Investopedia
Apr-19-18 08:00AM  Trending: Investors Apathetic to Barclays' $1.2 Billion ETN Shutoff ETF Database
Apr-18-18 04:08PM  Why These Small Cap Biotech ETFs are Soaring Zacks
Apr-17-18 02:06PM  What strong global growth means for US markets CNBC Videos
Apr-13-18 01:53PM  Earnings bar too high? Experts weigh in CNBC Videos
Apr-12-18 11:48AM  3 Biotech Stocks Analysts Have Been Too Bullish On Investopedia
Apr-09-18 05:31AM  Exact Sciences Corporation Could Break Out Despite Steep Drop in Biotech InvestorPlace
Apr-06-18 02:53PM  Biotech's Exact Sciences Seen Plunging 25% Investopedia
Apr-04-18 09:54AM  Biotech Sector Could See New Life
Apr-02-18 02:54PM  Alkermes FDA Refusal: Biotech ETFs Dragged Down ETF Trends
Mar-20-18 07:12PM  Cramer Remix: Here's how Mark Zuckerberg should respond t... CNBC Videos
07:03PM  Cramer: These charts show 'signs of life' for biotech CNBC Videos
06:45PM  Cramer's charts show 'signs of life' for the struggling b... CNBC Videos
Mar-19-18 04:15PM  The 4 Top Biotech ETFs Motley Fool
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.